Fig. 2From: Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre studyKaplan-Meier survival curve with cumulative probability of composite unfavorable outcome (death and or ART failure at 24 months)Back to article page